Legal but lethal: functional protein aggregation at the verge of toxicity

Angelika Falsone1, S Fabio Falsone1

  • 1Institute of Pharmaceutical Sciences, University of Graz Graz, Austria.

Insights

Protein aggregation, often linked to neurodegenerative diseases, can also serve beneficial physiological roles. Organisms have strategies to manage beneficial protein aggregation while preventing toxic accumulation.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Cell Biology

Background:

  • Protein aggregation is a hallmark of neurodegenerative disorders, typically associated with cellular toxicity and damage.
  • Emerging evidence suggests that protein aggregation can also fulfill essential physiological functions, exemplified by prions.
  • While initially viewed as solely toxic, many proteins exhibit prion-like properties for organized polymerization into functional complexes.

Purpose of the Study:

  • To review the strategies employed by living organisms to maintain beneficial protein aggregation.
  • To explore mechanisms preventing the detrimental accumulation of toxic protein aggregates.

Main Methods:

  • Literature review of studies on protein aggregation in various organisms.
  • Analysis of cellular and molecular mechanisms governing protein polymerization.
  • Examination of prion biology and prion-like protein behavior.

Main Results:

  • Cells can tolerate the accumulation of potentially harmful protein aggregates for functional benefits.
  • Organisms possess distinct strategies to differentiate between beneficial and detrimental protein aggregation.
  • Prion-like attributes are utilized by various proteins for organized physiological roles.

Conclusions:

  • Protein aggregation is a complex biological process with both pathological and physiological implications.
  • Understanding the balance between beneficial and toxic aggregation is crucial for neurodegenerative disease research.
  • Cellular mechanisms exist to harness protein aggregation for functional advantage, challenging the solely detrimental view.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Amyloid Fibrils03:03

Amyloid Fibrils

7.0K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
21.0K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.7K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K